Sun Pharmaceutical Industries Limited's latest marketcap:
As of 06/26/2025, Sun Pharmaceutical Industries Limited's market capitalization has reached $46.56 B. According to our data, Sun Pharmaceutical Industries Limited is the 468th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 46.56 B |
| Revenue (ttm) | 6.11 B |
| Net Income (ttm) | 1.27 B |
| Shares Out | 2.4 B |
| EPS (ttm) | 0.53 |
| Forward PE | 32.12 |
| Ex-Dividend Date | 07/07/2025 |
| Earnings Date | 07/31/2025 |
Sun Pharmaceutical Industries Limited's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | ₹46.56 B | -11.87% | 468 |
| 12/31/2024 | ₹4.53 T | 49.78% | 358 |
| 12/29/2023 | ₹3.02 T | 25.77% | 505 |
| 12/30/2022 | ₹2.4 T | 18.41% | 582 |
| 12/31/2021 | ₹2.03 T | 42.77% | 747 |
| 12/31/2020 | ₹1.42 T | 36.94% | 898 |
| 12/31/2019 | ₹1.04 T | 0.48% | 948 |
| 12/31/2018 | ₹1.03 T | -24.62% | 764 |
| 12/29/2017 | ₹1.37 T | -9.34% | 608 |
| 12/30/2016 | ₹1.51 T | -23.42% | 477 |
Company Profile
About Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited is a leading generic pharmaceutical company that develops, manufactures, and markets branded and generic formulations, as well as active pharmaceutical ingredients (APIs) globally.
Product Portfolio
The company offers a diverse range of formulations across multiple therapeutic areas, including:
- Central Nervous System
- Dermatology & Cardiology
- Oncology & Neuropsychiatry
- Gastroenterology & Anti-infectives
- Diabetology & Pain/Analgesics
- Vitamins/Minerals/Nutrients
- Respiratory & Gynaecology
- Ophthalmology & Orthopaedics
- Nephrology & Dental Care
Key Offerings
- APIs: Anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs.
- Generic Medications: Tablets, capsules, injectables, inhalers, ointments, creams, and liquids.
- Specialty & OTC Products: Including antiretrovirals and over-the-counter medications.
Company Background
Founded in 1983, Sun Pharmaceutical Industries is headquartered in Mumbai, India, and has established itself as a key player in the global pharmaceutical market.
Frequently Asked Questions
-
What is Sun Pharmaceutical Industries Limited's (NSE-SUNPHARMA) current market cap?As of 06/26/2025, Sun Pharmaceutical Industries Limited (including the parent company, if applicable) has an estimated market capitalization of $46.56 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Sun Pharmaceutical Industries Limited (NSE-SUNPHARMA) rank globally by market cap?Sun Pharmaceutical Industries Limited global market capitalization ranking is approximately 468 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.